Blue light is produced naturally by the sun and generated by computer monitors, smartphone screens and other digital devices. Although the light has some beneficial effects, exposure can increase ...View Article
You are using an outdated browser. Please upgrade your browser to improve your experience.
Diagnostics and Testing
A Complete Approach
To start the exam, patients are handed a questionnaire which focuses on the severity and frequency of your symptoms. An elevated result can indicate that you may be suffering from chronic dry eye disease. Your doctor will sit down with you to discuss the history and severity of your symptoms.
The doctors at Michiana Eye Center have a variety of advanced diagnostic tests at their disposal, using Tearlab Osmolarity, InflammaDry MMP-9 testing, Meibography and a variety of staining techniques to evaluate and manage your disease.
Testing can result in error. In order to get the most accurate readings, we ask that all patients:
All of our five locations are Clinical Labratory Improvement Amendments (CLIA) certified to preform TearLab Osmolarity testing to measure the salt concentration of your tears. Using a quantitative scale our doctors can diagnose the severity of your dry eye. An elevated reading or variability between the eyes can indicate ocular surface disease and help our doctors develop an appropriate treatment plan.
The InflammaDry system allows our doctors to analyze your eye surface for the presence of Matrix Metallopeptidase 9, or MMP-9, a genetic marker commonly found in abundance in patients with dry eye disease. Within ten minutes, our doctors are able to further diagnose your condition and provide the best treatment available.
The slit lamp examination is arguably the most important aspect of the dry eye exam. During this time, your doctor will observe and evaluate the cornea of the eye and use techniques such as:
When your chronic dry eye symptoms are related to Meibomian gland dysfunction (MGD), your doctor can monitor and document your progress using advanced infrared imaging technology. By so doing, your doctors can determine any obstructed or missing glands. At Michiana Eye Center we have two state-of-the-art instruments dedicated to this: the LipiView II and the Oculus Keratograph 5M.
The LipiView II is a multi-tool device that allows our doctors to fully examine your blink rate, lipid layer and meibomian glands. Along with focusing on a patient's meibography, the LipiView II also analyzes for any incomplete blinks from our patients, signaling that the lipid layer of your tears is not being properly distributed. Using color maps the LipiView II also allows doctors to see the quality of the lipid layers being produced.
The Oculus Keratograph® 5M is a combination instrument that uses multi-spectrum light to measure the severity of MGD using empirical observations.The Oculus also allows our doctors to monitor your NIK-TBUT (Non-Invasive Keratograph Tear Break-Up Time). Breaking your cornea into sections, doctors can pinpoint exactly where your tears begin to evaporate off the ocular surface.
Applying the same pressure as a complete blink, the Korb Meibomian Gland Evaluator allows doctors to assess the function of your meibomian glands.
The new Sjö Test allows our doctors to take an in-office blood sample from our patients and send them for an evaluation for genetic makers common to Sjögren's syndrome. A serious autoimmune disease, Sjögren's affects more than 4 million people in the United States with most cases not diagnosed until 3.5 years after symptoms arise. What makes the Sjö Test different is not only does it screen for the 4 most traditional makers but also 3 novel markers. Test results are shared with the patient by either fax or email and a copy is send back to your provider.
Your Michiana Eye Center physician will prescribe a treatment plan that is as unique as you. We understand that simply diagnosing your disease does not offer you the treatment and relief that you demand. Unlike many other groups, Michiana Eye Center offers many solutions in-house, as well as at-home treatments.